Concurrent 7C - What’s new in prostate cancer screening
Tracks
Track 5
| Saturday, November 21, 2026 |
| 10:45 - 11:30 |
| Hall B |
Details
This session will provide an overview of the 2026 changes in prostate cancer screening in Australia, based on the updated Prostate Cancer Foundation of Australia (PCFA) Clinical guidelines for PSA testing.
This workshop will provide an overview of the key evidence-based recommendations that GPs and their patients need to know, including practical conversation strategies that GPs can use with their patients when considering prostate cancer screening.
Speaker
Prof Mark Morgan
Academic (incl Professor)
Bond University
What’s new in prostate cancer screening
Professor Mark Morgan trained in general practice in the UK. He has worked both in rural and urban Australia as a GP, educator and researcher. His research interests include patient safety, primary care data, shared decision making and the management of patients with multiple long-term medical conditions. Mark is the Chair of the RACGP Expert Committee for Quality Care (REC-QC). Mark chairs the steering committee for the First do no harm guide and was on the Expert committee for the 10th ed RACGP Red book. At Bond University Faculty of Health, Science and Medicine, Mark is the Associate Dean for External Engagement and teaches within the Medical Program.
Dr Matthew Roughan
GP in Training
University Of Queensland
Chairperson
10:45 - 11:30
Matthew is a final year GP registrar completing his second academic post at UQ. He has an interest in public health and has spent time working throughout Queensland and the NT.